Ganciclovir

Ganciclovir is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults who are immunocompromised, including individuals with AIDS. Ganciclovir is also FDA-approved for the prevention of CMV disease in recipients of organ transplants who are at risk for CMV diseases. It is grouped under the following drug class(es): DNA polymerase inhibitors and Nucleosides. Its therapeutic use is listed as anti-infectives, antivirals and ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Cytovene, Vitrasert and Zirgan. Its PubChem CID is 135398740.